Chemotactic activity of S100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1499-1506

  Wolf, Ronald ^a   Howard, O M Zack ^b   Dong, Hui Fang ^c   Voscopoulos, Christopher ^a   Boeshans, Karen ^d   Winston, Jason ^a   Divi, Rao ^a   Gunsior, Michele ^a   Goldsmith, Paul ^a   Ahvazi, Bijan ^d   Chavakis, Triantafyllos ^a   Oppenheim, Joost J ^b   Yuspa, Stuart H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PSORIASIN; S100A15 PROTEIN; UNCLASSIFIED DRUG; ZINC; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN RECEPTOR; PROTEIN S 100; S100A7 PROTEIN, HUMAN; S100A7A PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL SUBPOPULATION; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SKIN CELL; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; KERATINOCYTE; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; CHEMOTAXIS, LEUKOCYTE; HUMANS; INFLAMMATION; KERATINOCYTES; LYMPHOCYTE SUBSETS; MICE; MICE, KNOCKOUT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS;

EID: 49049094277     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1499     Document Type: Article

References (50)

1. Madsen, P., H. H. Rasmussen, H. Leffers, B. Honore, K. Dejgaard, E. Olsen, J. Kiil, E. Walbum, A. H. Andersen, B. Basse, et al. 1991. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 97: 701-712.
2. Boniface, K., F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174: 3695-3702. (Pubitemid 40354080)
3. Boniface, K., C. Diveu, F. Morel, N. Pedretti, J. Froger, E. Ravon, M. Garcia, E. Venereau, L. Preisser, E. Guignouard, et al. 2007. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J. Immunol. 178: 4615-4622. (Pubitemid 46492414)
4. Eckert, R. L., A. M. Broome, M. Ruse, N. Robinson, D. Ryan, and K. Lee. 2004. S100 proteins in the epidermis. J. Invest. Dermatol. 123: 23-33.
5. Wolk, K., E. Witte, E. Wallace, W. D. Docke, S. Kunz, K. Asadullah, H. D. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36: 1309-1323.
6. Wolf, R., A. Mirmohammadsadegh, M. Walz, B. Lysa, U. Tartler, R. Remus, U. Hengge, G. Michel, and T. Ruzicka. 2003. Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J. 17: 1969-1971.
7. Donato, R. 2003. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60: 540-551.
8. Heizmann, C. W., G. Fritz, and B. W. Schafer. 2002. S100 proteins: structure, functions and pathology. Front. Biosci. 7: d1356-d1368.
9. Kulski, J. K., C. P. Lim, D. S. Dunn, and M. Bellgard. 2003. Genomic and phylogenetic analysis of the S100A7 (psoriasin) gene duplications within the region of the S100 gene cluster on human chromosome 1q21. J. Mol. Evol. 56: 397-406.
10. Wolf, R., C. J. Voscopoulos, P. C. FitzGerald, P. Goldsmith, C. Cataisson, M. Gunsior, M. Walz, T. Ruzicka, and S. H. Yuspa. 2006. The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and proteinprocessing pattern of the human S100A7/A15 subfamily during epidermal maturation. J. Invest. Dermatol. 126: 1600-1608. (Pubitemid 43910377)
11. Boeshans, K. M., R. Wolf, C. Voscopoulos, W. Gillette, D. Esposito, T. C. Mueser, S. H. Yuspa, and B. Ahvazi. 2006. Purification, crystallization, and preliminary X-ray diffraction of human S100A15. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62: 467-470. (Pubitemid 43806735)
12. Orlova, V. V., E. Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C. M. Ballantyne, C. G. Gahmberg, M. E. Bianchi, P. P. Nawroth, and 1505 The Journal of Immunology T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26: 1129-1139.
13. Glaser, R., J. Harder, H. Lange, J. Bartels, E. Christophers, and J. M. Schroder. 2005. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6: 57-64. (Pubitemid 40136696)
14. Chertov, O., H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Howard, T. J. Sayers, and J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186: 739-747. (Pubitemid 27381538)
15. Chavakis, T., A. Bierhaus, N. Al Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198: 1507-1515. (Pubitemid 37467165)
16. Foell, D., H. Wittkowski, T. Vogl, and J. Roth. 2007. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukocyte Biol. 81: 28-37. (Pubitemid 46021248)
17. Harrison, C. A., M. J. Raftery, J. Walsh, P. Alewood, S. E. Iismaa, S. Thliveris, and C. L. Geczy. 1999. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem. 274: 8561-8569.
18. Oppenheim, J. J., D. Yang, A. Biragyn, O. M. Howard, and P. Plotz. 2002. Chemokine receptors on dendritic cells promote autoimmune reactions. Arthritis Res. 4 (Suppl. 3): S183-S188.
19. Hromas, R., H. E. Broxmeyer, C. Kim, H. Nakshatri, K. Christopherson, M. Azam, and Y. H. Hou. 1999. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255: 703-706. (Pubitemid 29294862)
20. Vorum, H., P. Madsen, H. H. Rasmussen, M. Etzerodt, I. Svendsen, J. E. Celis, and B. Honore. 1996. Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin. Electrophoresis 17: 1787-1796. (Pubitemid 26402938)
21. 2+-free states. Biochemistry 38: 1695-1704.
22. Nakamae-Akahori, M., T. Kato, S. Masuda, E. Sakamoto, H. Kutsuna, F. Hato, Y. Nishizawa, M. Hino, and S. Kitagawa. 2006. Enhanced neutrophil motility by granulocyte colony-stimulating factor: the role of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Immunology 119: 393-403. (Pubitemid 44571058)
23. Algermissen, B., J. Sitzmann, P. LeMotte, and B. Czarnetzki. 1996. Differential expression of CRABP II, psoriasin, and cytokeratin 1 mRNA in human skin diseases. Arch. Dermatol. Res. 288: 426-430. (Pubitemid 26282734)
24. 1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem. Photobiol. 72: 374-382.
25. Wolf, R., V. Lewerenz, A. S. Buchau, M. Walz, and T. Ruzicka. 2007. Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Exp. Dermatol. 16: 685-691. (Pubitemid 47079599)
26. Buchau, A. S., M. Hassan, G. Kukova, V. Lewerenz, S. Kellermann, J. U. Wurthner, R. Wolf, M. Walz, R. L. Gallo, and T. Ruzicka. 2007. S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor 4. J. Invest. Dermatol. 127: 2596-2604.
27. Lee, K. C., and R. L. Eckert. 2007. S100A7 (psoriasin): mechanism of antibacterial action in wounds. J. Invest. Dermatol. 127: 945-957.
28. Schroder, J. M., and J. Harder. 2006. Antimicrobial skin peptides and proteins. Cell Mol. Life Sci. 63: 469-486.
29. Griffiths, C. E. 2003. The immunological basis of psoriasis. J. Eur. Acad. Dermatol. Venereol. 17 (Suppl. 2): 1-5.
30. Lew, W., A. M. Bowcock, and J. G. Krueger. 2004. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "type 1" inflammatory gene expression. Trends Immunol. 25: 295-305. (Pubitemid 38610353)
31. Al Haddad, S., Z. Zhang, E. Leygue, L. Snell, A. Huang, Y. Niu, T. Hiller-Hitchcock, K. Hole, L. C. Murphy, and P. H. Watson. 1999. Psoriasin (S100A7) expression and invasive breast cancer. Am. J. Pathol. 155: 2057-2066.
32. Daly, C., and B. J. Rollins. 2003. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10: 247-257. (Pubitemid 39004252)
33. Luster, A. D., R. Alon, and U. H.von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190.
34. Jinquan, T., H. Vorum, C. G. Larsen, P. Madsen, H. H. Rasmussen, B. Gesser, M. Etzerodt, B. Honore, J. E. Celis, and K. Thestrup-Pedersen. 1996. Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 107: 5-10.
35. Bierhaus, A., P. M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D. M. Stern, and P. P. Nawroth. 2005. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886. (Pubitemid 41598688)
36. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. M. Stern. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955.
37. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
38. Sorci, G., F. Riuzzi, A. L. Agneletti, C. Marchetti, and R.Donato. 2003. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23: 4870-4881. (Pubitemid 36793333)
39. Deane, R., Y. S. Du, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, et al. 2003. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9: 907-913. (Pubitemid 36889934)
40. Dumitriu, I. E., P. Baruah, A. A. Manfredi, M. E. Bianchi, and P. Rovere-Querini. 2005. HMGB1: guiding immunity from within. Trends Immunol. 26: 381-387.
41. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
42. Park, L., K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran, Jr., W. S. Chow, D. Stern, and A. M. Schmidt. 1998. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4: 1025-1031. (Pubitemid 28417334)
43. Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, et al. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360. (Pubitemid 30337069)
44. Cornish, C. J., J. M. Devery, P. Poronnik, M. Lackmann, D. I. Cook, and C. L. Geczy. 1996. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166: 427-437.
45. Komada, T., R. Araki, K. Nakatani, I. Yada, M. Naka, and T. Tanaka. 1996. Novel specific chemotactic receptor for S100L protein on guinea pig eosinophils. Biochem. Biophys. Res. Commun. 220: 871-874. (Pubitemid 26198604)
46. Miranda, L. P., T. Tao, A. Jones, I. Chernushevich, K. G. Standing, C. L. Geczy, and P. F. Alewood. 2001. Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). FEBS Lett. 488: 85-90.
47. Xie, J., D. S. Burz, W. He, I. B. Bronstein, I. Lednev, and A. Shekhtman. 2007. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282: 4218-4231. (Pubitemid 47084493)
48. Santamaria-Kisiel, L., A. C. Rintala-Dempsey, and G. S. Shaw. 2006. Calciumdependent and -independent interactions of the S100 protein family. Biochem. J. 396: 201-214. (Pubitemid 43837235)
49. Zimmer, D. B., S. P. Wright, and D. J. Weber. 2003. Molecular mechanisms of S100-target protein interactions. Microsc. Res. Tech. 60: 552-559.
50. Ravasi, T., K. Hsu, J. Goyette, K. Schroder, Z. Yang, F. Rahimi, L. P. Miranda, P. F. Alewood, D. A. Hume, and C. Geczy. 2004. Probing the S100 protein family through genomic and functional analysis. Genomics 84: 10-22. (Pubitemid 38760126)